176 related articles for article (PubMed ID: 22157398)
1. Biology and pharmacology of bombesin receptor subtype-3.
Majumdar ID; Weber HC
Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
[TBL] [Abstract][Full Text] [Related]
2. Appetite-modifying effects of bombesin receptor subtype-3 agonists.
Majumdar ID; Weber HC
Handb Exp Pharmacol; 2012; (209):405-32. PubMed ID: 22249826
[TBL] [Abstract][Full Text] [Related]
3. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
4. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity.
Ohki-Hamazaki H; Watase K; Yamamoto K; Ogura H; Yamano M; Yamada K; Maeno H; Imaki J; Kikuyama S; Wada E; Wada K
Nature; 1997 Nov; 390(6656):165-9. PubMed ID: 9367152
[TBL] [Abstract][Full Text] [Related]
6. Human BRS-3 receptor: functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes.
Ramos-Álvarez I; Moreno-Villegas Z; Martín-Duce A; Sanz R; Aparicio C; Portal-Núñez S; Mantey SA; Jensen RT; González N
Peptides; 2014 Jan; 51():91-9. PubMed ID: 24220502
[TBL] [Abstract][Full Text] [Related]
7. Bombesin receptor subtype 3 as a potential target for obesity and diabetes.
González N; Moreno P; Jensen RT
Expert Opin Ther Targets; 2015; 19(9):1153-70. PubMed ID: 26066663
[TBL] [Abstract][Full Text] [Related]
8. Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
Metzger JM; Gagen K; Raustad KA; Yang L; White A; Wang SP; Craw S; Liu P; Lanza T; Lin LS; Nargund RP; Guan XM; Strack AM; Reitman ML
Am J Physiol Endocrinol Metab; 2010 Nov; 299(5):E816-24. PubMed ID: 20807840
[TBL] [Abstract][Full Text] [Related]
9. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
[TBL] [Abstract][Full Text] [Related]
11. Extraintestinal roles of bombesin-like peptides and their receptors: lung.
Qin XQ; Qu X
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):22-6. PubMed ID: 23222852
[TBL] [Abstract][Full Text] [Related]
12. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
13. Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity.
Guan XM; Chen H; Dobbelaar PH; Dong Y; Fong TM; Gagen K; Gorski J; He S; Howard AD; Jian T; Jiang M; Kan Y; Kelly TM; Kosinski J; Lin LS; Liu J; Marsh DJ; Metzger JM; Miller R; Nargund RP; Palyha O; Shearman L; Shen Z; Stearns R; Strack AM; Stribling S; Tang YS; Wang SP; White A; Yu H; Reitman ML
Cell Metab; 2010 Feb; 11(2):101-12. PubMed ID: 20096642
[TBL] [Abstract][Full Text] [Related]
14. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
[TBL] [Abstract][Full Text] [Related]
15. Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells.
Ramos-Álvarez I; Nakamura T; Mantey SA; Moreno P; Nuche-Berenguer B; Jensen RT
Peptides; 2016 Jan; 75():8-17. PubMed ID: 26524625
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
[TBL] [Abstract][Full Text] [Related]
17. Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonists.
Lo MM; Chobanian HR; Palyha O; Kan Y; Kelly TM; Guan XM; Reitman ML; Dragovic J; Lyons KA; Nargund RP; Lin LS
Bioorg Med Chem Lett; 2011 Apr; 21(7):2040-3. PubMed ID: 21354793
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.
Ladenheim EE; Hamilton NL; Behles RR; Bi S; Hampton LL; Battey JF; Moran TH
Endocrinology; 2008 Mar; 149(3):971-8. PubMed ID: 18039774
[TBL] [Abstract][Full Text] [Related]
19. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
[TBL] [Abstract][Full Text] [Related]
20. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
